
cbdMD
(NYSEMKT) YCBD
cbdMD Financials at a Glance
Market Cap
$7.38M
Revenue (TTM)
$19.98M
Net Income (TTM)
-$2.66M
EPS (TTM)
-$0.41
P/E Ratio
-1.72
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.74
Volume
233,106
Open
$0.70
Price
$0.74
Volume
233,106
Open
$0.70
Previous Close
$0.70
Daily Range
$0.69 - $0.74
52-Week Range
$0.47 - $2.56
Estimated Earnings Date
Aug 19, 2026
Dividend
$0.00
Beta (Volatility)
0.90 (Low)
Price
$0.74
Volume
233,106
Open
$0.70
Previous Close
$0.70
Daily Range
$0.69 - $0.74
52-Week Range
$0.47 - $2.56
Estimated Earnings Date
Aug 19, 2026
YCBD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout cbdMD
Industry
Pharmaceuticals
Sector
Health CareEmployees
42
CEO
T. Ronan Kennedy, MBA
Website
www.cbdmd.comHeadquarters
Charlotte, NC 28217, US
YCBD Financials
Key Financial Metrics (TTM)
Gross Margin
58.12%
Operating Margin
-13.40%
Net Income Margin
-13.29%
Return on Equity
-33.59%
Return on Capital
-0.28%
Return on Assets
-21.68%
Earnings Yield
-58.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.38M
Shares Outstanding
10.50M
Volume
233.11K
Avg. Volume
1.37M
Financials (TTM)
Gross Profit
$11.61M
Operating Income
-$2.68M
EBITDA
-$935.93K
Operating Cash Flow
-$2.48M
Capital Expenditure
-$164.81M
Free Cash Flow
-$166.48M
Cash & ST Invst.
$2.64M
Total Debt
$415.13K
cbdMD Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.64M
+18.8%
Gross Profit
$3.01M
+1.6%
Gross Margin
53.29%
N/A
Market Cap
$7.38M
N/A
Market Cap/Employee
$175.71K
N/A
Employees
42
N/A
Net Income
-$797.98K
-66.0%
EBITDA
-$375.24K
-495.1%
Quarterly Fundamentals
Total Cash
$2.64M
+49.5%
Total Debt
$415.13K
-63.7%
Accounts Receivable
$1.57M
+49.5%
Inventory
$3.32M
+24.7%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$415.13K
-44.3%
Return on Assets
-21.68%
N/A
Return on Invested Capital
-28.84%
N/A
Free Cash Flow
-$728.25K
-255.3%
Operating Cash Flow
-$722.50K
-281.3%